Semaglutide SM2 SM5 SM10 SM15 SM20 SM30 SM50 Peptide Raw Material Manufacturer
Pharmaceutical Grade
99%
shanghai
JL
10VIALS PER BOX
2027-11-30
Peptide
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Semaglutide SM2 SM5 SM10 SM15 SM20 SM30 SM50
Categories:
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
zhejiangshengjinhuashiyiwushijiangdongjiedaodongnanlu656hao
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Safe Deliver Cerebrolysin CBL60 99% purity powder weight loss customizable peptide CAS12656-61-0
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-
-
-
-
G210 G610 Pharmaceutical Grade Lyophilized Powder safe delicery high purity
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
KPV Manufacturer 99% Purity Bulk KPV CAS Number 67727-97-3 Peptide KP5 KP10 5mg 10mg
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-
-
-
-
99%CAS 1401708-83-5 Top QualityDihexa/PNB-0408 Peptide
Pharmaceutical Grade / 99%
$33-36/UNIT FOB
-
-
-
-
CD5 high purity 99% safe delivery lyophilized powder pharmaceutical grade
Pharmaceutical Grade / 99%
$1/UNIT FOB
-
-
-
-
BB10 BB20 BB30 high purity 99% safe delivery lyophilized powder pharmaceutical grade
Pharmaceutical Grade / 99%
$1/UNIT FOB
-